Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Clinical Nuclear Medicine
|
June 5, 2023
Discriminating Inflammatory Radiation-Related Changes From Early Recurrence in Patients With Glioblastomas: A Preliminary Analysis of 68 Ga-PSMA-11 PET/CT Compared With 18 F-FDOPA PET/CT
Aurélie Moreau, Fouzi Khayi, Aurélien Maureille, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 21, 2009
Influence of multidrug resistance on (18)F-FCH cellular uptake in a glioblastoma model
Claire Vanpouille, Nathalie Le Jeune, David Kryza, et al.
EJNMMI Radiopharmacy and Chemistry
|
June 23, 2026
Fully GMP-complient radiosynthesis of [<sup>161</sup>Tb]Tb-PSMA-1 using the miniAiO synthesizer for clinical translation
David Kryza, Pierre Le Fur, Jean Noël Badel, et al.
EJNMMI Radiopharmacy and Chemistry
|
April 2, 2024
Improved automated one-pot two-step radiosynthesis of (S)-[<sup>18</sup>F]FETrp, a radiotracer for PET imaging of indoleamine 2,3-dioxygenase 1 (IDO1)
Aurélie Maisonial-Besset, David Kryza, Klaus Kopka, et al.
Bioconjugate Chemistry
|
December 29, 2017
Granulocyte-Colony Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part II): Dose-Dependent Biodistribution and In Vivo Antitumor Efficacy in Combination with Rituximab
David Kryza, Gabriel De Crozals, Doriane Mathe, et al.
European Urology Focus
|
May 26, 2026
Radioligand Therapy (RLT) in France
Anne-Laure Giraudet, David Kryza, Lavinia Vija, et al.
Journal of Cancer Research and Clinical Oncology
|
June 5, 2025
Radiopharmaceutical application of TRK-950, an anti-CAPRIN-1 therapeutic antibody
Yuki Majima, David Kryza, Mitsuaki Sanada, et al.
Therapeutic Advances in Medical Oncology
|
November 1, 2021
PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?
Anne-Laure Giraudet, David Kryza, Michael Hofman, et al.
EJNMMI Physics
|
June 20, 2019
In vivo gadolinium nanoparticle quantification with SPECT/CT
Olga Kochebina, Adrien Halty, Jacqueline Taleb, et al.
Bioconjugate Chemistry
|
December 29, 2017
Granulocyte Colony-Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part I): Synthesis and Biodistribution Studies
Gabriel De Crozals, David Kryza, Gloria Jiménez Sánchez, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Clinical Nuclear Medicine
|
June 5, 2023
Discriminating Inflammatory Radiation-Related Changes From Early Recurrence in Patients With Glioblastomas: A Preliminary Analysis of 68 Ga-PSMA-11 PET/CT Compared With 18 F-FDOPA PET/CT
Aurélie Moreau, Fouzi Khayi, Aurélien Maureille, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 21, 2009
Influence of multidrug resistance on (18)F-FCH cellular uptake in a glioblastoma model
Claire Vanpouille, Nathalie Le Jeune, David Kryza, et al.
EJNMMI Radiopharmacy and Chemistry
|
June 23, 2026
Fully GMP-complient radiosynthesis of [<sup>161</sup>Tb]Tb-PSMA-1 using the miniAiO synthesizer for clinical translation
David Kryza, Pierre Le Fur, Jean Noël Badel, et al.
EJNMMI Radiopharmacy and Chemistry
|
April 2, 2024
Improved automated one-pot two-step radiosynthesis of (S)-[<sup>18</sup>F]FETrp, a radiotracer for PET imaging of indoleamine 2,3-dioxygenase 1 (IDO1)
Aurélie Maisonial-Besset, David Kryza, Klaus Kopka, et al.
Bioconjugate Chemistry
|
December 29, 2017
Granulocyte-Colony Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part II): Dose-Dependent Biodistribution and In Vivo Antitumor Efficacy in Combination with Rituximab
David Kryza, Gabriel De Crozals, Doriane Mathe, et al.
European Urology Focus
|
May 26, 2026
Radioligand Therapy (RLT) in France
Anne-Laure Giraudet, David Kryza, Lavinia Vija, et al.
Journal of Cancer Research and Clinical Oncology
|
June 5, 2025
Radiopharmaceutical application of TRK-950, an anti-CAPRIN-1 therapeutic antibody
Yuki Majima, David Kryza, Mitsuaki Sanada, et al.
Therapeutic Advances in Medical Oncology
|
November 1, 2021
PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?
Anne-Laure Giraudet, David Kryza, Michael Hofman, et al.
EJNMMI Physics
|
June 20, 2019
In vivo gadolinium nanoparticle quantification with SPECT/CT
Olga Kochebina, Adrien Halty, Jacqueline Taleb, et al.
Bioconjugate Chemistry
|
December 29, 2017
Granulocyte Colony-Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part I): Synthesis and Biodistribution Studies
Gabriel De Crozals, David Kryza, Gloria Jiménez Sánchez, et al.
Page
of 7